Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CIDOFOVIR vs CILASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CIDOFOVIR vs CILASTATIN: Safety Overview

Metric CIDOFOVIR CILASTATIN
Total FAERS Reports 715 117
Deaths Reported 165 29
Death Rate 23.1% 24.8%
Hospitalizations 238 42
Average Patient Age 34.7 yrs 59.9 yrs
% Female Patients 50.1% 32.2%
FDA Approval Date Jul 26, 2012 N/A
Manufacturer Mylan Institutional LLC Fresenius Kabi USA, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A